ArticleGynecologic oncology2020

Tamrintamab pamozirine (SC-003) in patients with platinum-resistant/refractory ovarian cancer: Findings of a phase 1 study.

Erika Hamilton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.